2007
DOI: 10.1002/mds.21320
|View full text |Cite
|
Sign up to set email alerts
|

New device to control combined lingual and palatal myoclonus

Abstract: Lingual myoclonus is a poorly understood disorder that may occur in isolation or combined with palatal myoclonus. In this report, we present the case history of a 21-year-old patient with a therapy-resistant essential lingual and palatal myoclonus where a simple dental device was able to control symptoms. The use of this device will be highlighted and compared to previously described methods. Cases of previously recorded lingual and palatal myoclonus will be reviewed and compared to the case of our patient.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…Though considered controversial [110], there are no other epidemiological data to the contrary [111]. Thus there is a reported association of ET with PD [112,113,114,115], ET with AD [95,116,117] and ET with PSP [39,118]. It will be important to identify the subgroups of patients who are at increased risk for each of these entities.…”
Section: Resultsmentioning
confidence: 99%
“…Though considered controversial [110], there are no other epidemiological data to the contrary [111]. Thus there is a reported association of ET with PD [112,113,114,115], ET with AD [95,116,117] and ET with PSP [39,118]. It will be important to identify the subgroups of patients who are at increased risk for each of these entities.…”
Section: Resultsmentioning
confidence: 99%
“…Other non-pharmacological options include the administration of botulinum toxin, a safe and effective therapy in selected patients with SPT, and marginal benefits using special dental devices that have been used by some authors in patients with lingual-palatal tremor [16][17][18] .…”
Section: Discussionmentioning
confidence: 99%
“…However, again, a specific therapy for this disorder eludes us. ( Mondria et al, 2007 ). Our patient was initially started on levetiracetam which has been shown to be of benefit in cortical subcortical and brainstem lesions( Levy and Chen, 2016 ), which unfortunately failed to ameliorate his symptoms.…”
Section: Discussionmentioning
confidence: 99%